annual EBIT:
$84.28M+$157.66M(+214.85%)Summary
- As of today (May 18, 2025), ACAD annual earnings before interest & taxes is $84.28 million, with the most recent change of +$157.66 million (+214.85%) on December 31, 2024.
- During the last 3 years, ACAD annual EBIT has risen by +$254.72 million (+149.45%).
- ACAD annual EBIT is now at all-time high.
Performance
ACAD EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
$19.29M+$12.30M(+176.04%)Summary
- As of today (May 18, 2025), ACAD quarterly earnings before interest & taxes is $19.29 million, with the most recent change of +$12.30 million (+176.04%) on March 31, 2025.
- Over the past year, ACAD quarterly EBIT has increased by +$4.08 million (+26.82%).
- ACAD quarterly EBIT is now -44.80% below its all-time high of $34.94 million, reached on December 31, 2023.
Performance
ACAD quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
$88.36M+$4.08M(+4.84%)Summary
- As of today (May 18, 2025), ACAD TTM earnings before interest & taxes is $88.36 million, with the most recent change of +$4.08 million (+4.84%) on March 31, 2025.
- Over the past year, ACAD TTM EBIT has increased by +$92.94 million (+2027.13%).
- ACAD TTM EBIT is now -21.27% below its all-time high of $112.23 million, reached on September 30, 2024.
Performance
ACAD TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
ACAD EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +214.8% | +26.8% | +2027.1% |
| 3 y3 years | +149.4% | +117.1% | +140.8% |
| 5 y5 years | +134.2% | +121.5% | +135.6% |
ACAD EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +137.7% | -44.8% | +117.1% | -21.3% | +139.5% |
| 5 y | 5-year | at high | +129.4% | -44.8% | +117.1% | -21.3% | +130.8% |
| alltime | all time | at high | +128.8% | -44.8% | +117.1% | -21.3% | +128.4% |
ACAD EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $19.29M(+176.0%) | $88.36M(+4.8%) |
| Dec 2024 | $84.28M(-214.9%) | $6.99M(-77.9%) | $84.28M(-24.9%) |
| Sep 2024 | - | $31.64M(+4.0%) | $112.23M(+391.9%) |
| Jun 2024 | - | $30.44M(+100.1%) | $22.82M(-597.6%) |
| Mar 2024 | - | $15.21M(-56.5%) | -$4.58M(-93.8%) |
| Dec 2023 | -$73.38M(-67.2%) | $34.94M(-160.5%) | -$73.38M(-52.5%) |
| Sep 2023 | - | -$57.78M(-2002.4%) | -$154.39M(+21.1%) |
| Jun 2023 | - | $3.04M(-105.7%) | -$127.48M(-22.3%) |
| Mar 2023 | - | -$53.58M(+16.3%) | -$164.16M(-26.6%) |
| Dec 2022 | -$223.60M(+31.2%) | -$46.06M(+49.2%) | -$223.60M(+0.6%) |
| Sep 2022 | - | -$30.87M(-8.3%) | -$222.19M(+7.5%) |
| Jun 2022 | - | -$33.65M(-70.2%) | -$206.63M(-4.6%) |
| Mar 2022 | - | -$113.02M(+153.1%) | -$216.68M(+27.1%) |
| Dec 2021 | -$170.44M(-40.5%) | -$44.66M(+191.9%) | -$170.44M(-11.7%) |
| Sep 2021 | - | -$15.30M(-65.0%) | -$192.94M(-26.8%) |
| Jun 2021 | - | -$43.71M(-34.5%) | -$263.54M(-0.1%) |
| Mar 2021 | - | -$66.77M(-0.6%) | -$263.84M(-7.9%) |
| Dec 2020 | -$286.59M(+16.2%) | -$67.16M(-21.8%) | -$286.59M(+3.9%) |
| Sep 2020 | - | -$85.90M(+95.2%) | -$275.82M(+17.2%) |
| Jun 2020 | - | -$44.01M(-50.8%) | -$235.34M(-5.3%) |
| Mar 2020 | - | -$89.52M(+58.7%) | -$248.43M(+0.8%) |
| Dec 2019 | -$246.54M(-0.4%) | -$56.40M(+24.2%) | -$246.54M(-4.2%) |
| Sep 2019 | - | -$45.42M(-20.4%) | -$257.42M(-5.8%) |
| Jun 2019 | - | -$57.09M(-34.9%) | -$273.27M(-2.5%) |
| Mar 2019 | - | -$87.63M(+30.3%) | -$280.26M(+13.3%) |
| Dec 2018 | -$247.44M(-15.4%) | -$67.28M(+9.8%) | -$247.44M(-1.1%) |
| Sep 2018 | - | -$61.27M(-4.4%) | -$250.18M(-1.7%) |
| Jun 2018 | - | -$64.08M(+16.9%) | -$254.55M(-1.5%) |
| Mar 2018 | - | -$54.82M(-21.7%) | -$258.51M(-11.6%) |
| Dec 2017 | -$292.41M(+7.2%) | -$70.01M(+6.6%) | -$292.41M(-2.7%) |
| Sep 2017 | - | -$65.64M(-3.5%) | -$300.63M(-2.2%) |
| Jun 2017 | - | -$68.04M(-23.3%) | -$307.39M(-1.2%) |
| Mar 2017 | - | -$88.72M(+13.4%) | -$311.27M(+14.1%) |
| Dec 2016 | -$272.81M(+65.7%) | -$78.23M(+8.1%) | -$272.81M(+13.6%) |
| Sep 2016 | - | -$72.40M(+0.7%) | -$240.15M(+16.2%) |
| Jun 2016 | - | -$71.92M(+43.1%) | -$206.75M(+18.6%) |
| Mar 2016 | - | -$50.26M(+10.3%) | -$174.32M(+5.9%) |
| Dec 2015 | -$164.61M(+76.6%) | -$45.56M(+16.8%) | -$164.61M(+11.5%) |
| Sep 2015 | - | -$39.00M(-1.3%) | -$147.60M(+10.5%) |
| Jun 2015 | - | -$39.50M(-2.6%) | -$133.60M(+15.3%) |
| Mar 2015 | - | -$40.55M(+42.0%) | -$115.82M(+24.2%) |
| Dec 2014 | -$93.23M(+143.4%) | -$28.55M(+14.2%) | -$93.23M(+21.3%) |
| Sep 2014 | - | -$24.99M(+15.1%) | -$76.84M(+22.6%) |
| Jun 2014 | - | -$21.72M(+21.0%) | -$62.66M(+25.1%) |
| Mar 2014 | - | -$17.96M(+47.6%) | -$50.09M(+30.8%) |
| Dec 2013 | -$38.30M | -$12.16M(+12.5%) | -$38.30M(+16.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2013 | - | -$10.81M(+18.1%) | -$32.95M(+34.2%) |
| Jun 2013 | - | -$9.16M(+48.6%) | -$24.55M(+17.9%) |
| Mar 2013 | - | -$6.16M(-9.6%) | -$20.82M(-0.3%) |
| Dec 2012 | -$20.89M(-8.6%) | -$6.82M(+183.3%) | -$20.89M(+7.8%) |
| Sep 2012 | - | -$2.41M(-55.7%) | -$19.38M(-12.2%) |
| Jun 2012 | - | -$5.43M(-12.9%) | -$22.07M(-5.0%) |
| Mar 2012 | - | -$6.23M(+17.3%) | -$23.22M(+1.6%) |
| Dec 2011 | -$22.85M(-251.4%) | -$5.31M(+4.3%) | -$22.85M(-297.2%) |
| Sep 2011 | - | -$5.09M(-22.6%) | $11.59M(-6.8%) |
| Jun 2011 | - | -$6.58M(+12.3%) | $12.44M(-15.5%) |
| Mar 2011 | - | -$5.86M(-120.1%) | $14.73M(-2.4%) |
| Dec 2010 | $15.09M(-133.2%) | $29.13M(-786.7%) | $15.10M(-166.4%) |
| Sep 2010 | - | -$4.24M(-1.3%) | -$22.74M(-16.6%) |
| Jun 2010 | - | -$4.30M(-21.8%) | -$27.27M(-23.8%) |
| Mar 2010 | - | -$5.50M(-36.9%) | -$35.80M(-21.3%) |
| Dec 2009 | -$45.47M(-32.1%) | -$8.71M(-0.8%) | -$45.47M(-10.8%) |
| Sep 2009 | - | -$8.77M(-31.6%) | -$50.97M(-12.5%) |
| Jun 2009 | - | -$12.82M(-15.5%) | -$58.29M(-9.6%) |
| Mar 2009 | - | -$15.17M(+6.7%) | -$64.51M(-4.8%) |
| Dec 2008 | -$66.98M(+6.9%) | -$14.21M(-11.7%) | -$67.78M(-6.2%) |
| Sep 2008 | - | -$16.09M(-15.5%) | -$72.28M(-2.4%) |
| Jun 2008 | - | -$19.04M(+3.3%) | -$74.08M(+9.5%) |
| Mar 2008 | - | -$18.44M(-1.4%) | -$67.64M(+8.0%) |
| Dec 2007 | -$62.65M(+27.7%) | -$18.70M(+4.5%) | -$62.65M(+9.0%) |
| Sep 2007 | - | -$17.89M(+42.0%) | -$57.50M(+10.3%) |
| Jun 2007 | - | -$12.60M(-6.3%) | -$52.15M(-0.5%) |
| Mar 2007 | - | -$13.45M(-0.7%) | -$52.41M(+6.8%) |
| Dec 2006 | -$49.05M(+37.0%) | -$13.55M(+8.1%) | -$49.05M(+6.2%) |
| Sep 2006 | - | -$12.54M(-2.5%) | -$46.20M(-0.6%) |
| Jun 2006 | - | -$12.86M(+27.4%) | -$46.48M(+15.9%) |
| Mar 2006 | - | -$10.10M(-5.6%) | -$40.11M(+12.0%) |
| Dec 2005 | -$35.81M(+37.2%) | -$10.70M(-16.5%) | -$35.81M(+10.0%) |
| Sep 2005 | - | -$12.81M(+97.3%) | -$32.56M(+24.9%) |
| Jun 2005 | - | -$6.49M(+12.0%) | -$26.07M(+2.4%) |
| Mar 2005 | - | -$5.80M(-22.2%) | -$25.46M(-2.4%) |
| Dec 2004 | -$26.09M(+89.9%) | -$7.46M(+17.9%) | -$26.09M(-31.2%) |
| Sep 2004 | - | -$6.32M(+7.4%) | -$37.91M(+27.5%) |
| Jun 2004 | - | -$5.89M(-8.5%) | -$29.75M(+14.8%) |
| Mar 2004 | - | -$6.43M(-66.6%) | -$25.90M(+19.1%) |
| Dec 2003 | -$13.74M(+8.8%) | -$19.27M(-1144.9%) | -$21.75M(+777.5%) |
| Sep 2003 | - | $1.84M(-190.3%) | -$2.48M(-42.7%) |
| Jun 2003 | - | -$2.04M(-10.5%) | -$4.32M(+89.5%) |
| Mar 2003 | - | -$2.28M | -$2.28M |
| Dec 2002 | -$12.63M(-17.4%) | - | - |
| Dec 2001 | -$15.28M(+35.6%) | - | - |
| Dec 2000 | -$11.27M | - | - |
FAQ
- What is ACADIA Pharmaceuticals annual earnings before interest & taxes?
- What is the all time high annual EBIT for ACADIA Pharmaceuticals?
- What is ACADIA Pharmaceuticals annual EBIT year-on-year change?
- What is ACADIA Pharmaceuticals quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for ACADIA Pharmaceuticals?
- What is ACADIA Pharmaceuticals quarterly EBIT year-on-year change?
- What is ACADIA Pharmaceuticals TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for ACADIA Pharmaceuticals?
- What is ACADIA Pharmaceuticals TTM EBIT year-on-year change?
What is ACADIA Pharmaceuticals annual earnings before interest & taxes?
The current annual EBIT of ACAD is $84.28M
What is the all time high annual EBIT for ACADIA Pharmaceuticals?
ACADIA Pharmaceuticals all-time high annual earnings before interest & taxes is $84.28M
What is ACADIA Pharmaceuticals annual EBIT year-on-year change?
Over the past year, ACAD annual earnings before interest & taxes has changed by +$157.66M (+214.85%)
What is ACADIA Pharmaceuticals quarterly earnings before interest & taxes?
The current quarterly EBIT of ACAD is $19.29M
What is the all time high quarterly EBIT for ACADIA Pharmaceuticals?
ACADIA Pharmaceuticals all-time high quarterly earnings before interest & taxes is $34.94M
What is ACADIA Pharmaceuticals quarterly EBIT year-on-year change?
Over the past year, ACAD quarterly earnings before interest & taxes has changed by +$4.08M (+26.82%)
What is ACADIA Pharmaceuticals TTM earnings before interest & taxes?
The current TTM EBIT of ACAD is $88.36M
What is the all time high TTM EBIT for ACADIA Pharmaceuticals?
ACADIA Pharmaceuticals all-time high TTM earnings before interest & taxes is $112.23M
What is ACADIA Pharmaceuticals TTM EBIT year-on-year change?
Over the past year, ACAD TTM earnings before interest & taxes has changed by +$92.94M (+2027.13%)